Stocks to Watch: Disney, Confluent, Blue Bird
By Ben Glickman
Disney's global Disney+ streaming subscriber base was stable in the fiscal first quarter and its operating loss in its direct-to-consumer business narrowed. The entertainment company also announced a $1.5 billion deal for an equity stake in "Fortnite" video-game maker Epic Games and plans to stream a cut of Taylor Swift's Eras Tour concert movie. Shares rise 6.2% to $105.26 after-hours.
Confluent issued 2024 revenue guidance ahead of Wall Street's expectations after the company's revenue rose sharply again in the fourth quarter. Finance chief Rohan Sivaram said the company is expecting its first breakeven year in terms of adjusted operating margin and free cash flow margin. Shares rise 19% to $28.95 after-hours.
Blue Bird's fiscal first-quarter sales increased about 35%, topping analysts estimates with the help of higher selling prices and more units. The electric school bus maker lifted its guidance for adjusted Ebitda, or earnings before interest, tax, depreciation and amortization and swung to a profit. Shares rise 12% to $34.90 after-hours.
Write to Ben Glickman at ben.glickman@wsj.com
(END) Dow Jones Newswires
February 07, 2024 19:16 ET (00:16 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track